University of Oxford AstraZeneca COVID-19 vaccine to begin being manufactured in Australia this week


A COVID-19 vaccine is yet to achieve clinical approval, but doses will start to be manufactured in Australia this week.

CSL on Sunday confirmed it will commence manufacturing the University of Oxford/AstraZeneca coronavirus vaccine candidate in Victoria from Monday.

The ASX-listed biotechnology company has separate contracts with AstraZeneca and the federal government to manufacture approximately 30 million doses of the AZD1222 vaccine.

The first doses are planned for release in the first half of 2021, pending the outcome of clinical trials and regulatory approval.

The vaccine will not be released for use until the relevant clinical trial and manufacturing data are reviewed and approved by the Therapeutic Goods Administration.

CSL will make the AstraZeneca COVID-19 vaccine in Australia.
CSL will start making the AstraZeneca COVID-19 vaccine candidate in Australia from Monday. Credit: Reuters



Source link

×